HealthyDirect · GrowthFit for a long SIP
Axis Multicap Fund
Axis Mutual FundEquity Schemes - Multi Cap Fund4.9 years
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of equity and equity related instruments across market capitalization.
- NAV
- 20.21
- 29 Oct 2026
- 1Y
- +4.0%
- Trailing CAGR
- AUM
- ₹11,972.26 Cr
- 30 Sept 2026
- Volatility
- Medium
- 14.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 96% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
4.9 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.92% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
96% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Nitin Arora · 3.4 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 25.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+4.0%
- 3Y+18.9%
- 5Yn/a
- 10Yn/a
- SI+15.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+10.5%
- 3Y+10.5%
- 5Yn/a
- 10Yn/a
- Since inception
- +15.6%
- Calendar-day CAGR
- Excess 1Y
- +7.9%
- Category median, same plan and option
- 3Y win rate
- +96%
- Windows beating the median
- 3Y percentile
- 100
- Vs comparable share classes
- SIP 3Y XIRR
- +10.5%
- Simulated monthly SIP
- Worst rolling 3Y
- +17.0%
- 464 daily-ending windows
- Median rolling 3Y
- +22.6%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -18.1%
- Worst peak-to-trough
- Current
- -5.3%
- Below last peak
- Current spell
- 59 days
- Days below latest peak
- Time below peak
- +83%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 12 days
- 61 recovered episodes
- Longest recovery
- 243 days
- Trough to prior peak
26 Sept 2024 – 29 Oct 2025
Trough 28 Feb 2025 · recovered in 243 days
-18.1%
17 Jan 2022 – 12 Sept 2022
Trough 20 Jun 2022 · recovered in 84 days
-17.4%
29 Oct 2025 – 17 Jun 2026
Trough 23 Mar 2026 · recovered in 86 days
-13.4%
5 Dec 2022 – 15 May 2023
Trough 28 Mar 2023 · recovered in 48 days
-10.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
100
Consistency
77
Risk-adjusted
60
Drawdown
55
Mean
78
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 96% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 110 holdings · top 10 are 25.7%.
- Top 5
- 15.5%
- Top 10
- 25.7%
- Largest holding
- 4.6%
- Effective holdings
- 69.7
Others CBLO
Unspecified
4.6%
ICICI Bank Ltd
Financial
3.3%
HDFC Bank Ltd
Financial
2.7%
Sona BLW Precision Forgings Ltd
Consumer Discretionary
2.5%
Zomato Ltd
Technology
2.4%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
WhiteOak Capital Multi Cap Fund
WhiteOak Capital Mutual Fund
- 1Y
- +0.1%
- 3Y
- +17.8%
- Vol
- 14.5%
- Max DD
- -16.9%
- Sharpe
- 0.76
- 3Y win
- +100%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Lower trailing returns
Groww Multicap Fund
Groww Mutual Fund
- 1Y
- +10.8%
- 3Y
- n/a
- Vol
- 15.6%
- Max DD
- -16.5%
- Sharpe
- 0.34
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Higher TER · Lower trailing returns
HSBC Multi Cap Fund
HSBC Mutual Fund
- 1Y
- +0.7%
- 3Y
- +16.7%
- Vol
- 15.2%
- Max DD
- -20.1%
- Sharpe
- 0.94
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns
Kotak Multi Cap Fund
Kotak Mahindra Mutual Fund
- 1Y
- -4.1%
- 3Y
- +15.8%
- Vol
- 15.5%
- Max DD
- -21.0%
- Sharpe
- 0.63
- 3Y win
- +97%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns
UTI Multi Cap Fund
UTI Mutual Fund
- 1Y
- -4.3%
- 3Y
- n/a
- Vol
- 11.9%
- Max DD
- -14.1%
- Sharpe
- -0.25
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns